Extensive cutaneous viral warts during JAK inhibitor therapy for atopic dermatitis

Key Points

• Examine the occurrence of viral warts in patients undergoing JAK inhibitor therapy for atopic dermatitis.
• Reported observations of cutaneous warts in patients receiving JAK inhibitors
• Assessment of immune response alterations related to therapy
• Data obtained from clinical cases
• Patients exhibited a significant increase in the incidence of cutaneous viral warts
• Observations suggest a link between JAK inhibitor therapy and viral infections
• Implications for patient management and monitoring during treatment

Abstract